Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ping Gao

Showing results (521-530 of 1,655) with videos related to

Pageof 166
Sort By:
Zhonghua Nan Ke Xue = National Journal of Andrology|July 25, 2008
[Effects of a selective cyclooxygenase 2 inhibitor celecoxib on the proliferation and apoptosis of human prostate cancer cell line PC-3]Song Xu, Wen-quan Zhou, Zheng-yu Zhang, et al.
Zhonghua Nan Ke Xue = National Journal of Andrology|May 29, 2009
[Effects of endothelin A receptor antagonist BQ123 on the proliferation and apoptosis of prostate cancer cell line PC-3M]Song Xu, Wen-Quan Zhou, Zheng-Yu Zhang, et al.
Cancer Research|November 17, 2007
Silencing of prion protein sensitizes breast adriamycin-resistant carcinoma cells to TRAIL-mediated cell deathFranck Meslin, Ahmed Hamaï, Ping Gao, et al.
DNA and Cell Biology|December 14, 2011
Overexpression of SIRT6 in porcine fetal fibroblasts attenuates cytotoxicity and premature senescence caused by D-galactose and tert-butylhydroperoxideXiaoxian Xie, Hao Zhang, Ping Gao, et al.
Pharmaceutical Development and Technology|October 2, 2004
Application of a mixture experimental design in the optimization of a self-emulsifying formulation with a high drug loadPing Gao, Martha J Witt, Roy J Haskell, et al.
Bioorganic Chemistry|July 23, 2025
Targeting Urokinase-type plasminogen activator receptor (uPAR) in cancer therapy: Insights from the development of small-molecule inhibitorsHan Zhang, Zhinuo Xie, Song Xie, et al.
Frontiers in Pharmacology|November 12, 2025
Correction: Astragaloside IV alleviates tacrolimus-induced chronic nephrotoxicity via p62-Keap1-Nrf2 pathwayPing Gao, Xiaoyi Du, Lili Liu, et al.
Neurochemical Research|December 16, 2025
NEXN-AS1 Predicts the Occurrence of Post-Stroke Cognitive Impairment and Alleviates Inflammation and Oxidative Stress by Targeting the miR-92a-3p/NRF1 Axis : NEXN-AS1 Alleviates Inflammation and Oxidative Stress in PSCIKai Wang, Lu Yang, Chuanzhou Zhang, et al.
Diagnostic Pathology|June 27, 2013
RNAi targeting CXCR4 inhibits proliferation and invasion of esophageal carcinoma cellsTao Wang, Yanfang Mi, Linping Pian, et al.
American Journal of Cancer Research|July 27, 2017
UHRF1 promotes breast cancer progression by suppressing KLF17 expression by hypermethylating its promoterShui-Ping Gao, He-Fen Sun, Liang-Dong Li, et al.
Pageof 166

Showing results (521-530 of 1,655) with videos related to

Sort By:
Pageof 166
Zhonghua Nan Ke Xue = National Journal of Andrology|July 25, 2008
[Effects of a selective cyclooxygenase 2 inhibitor celecoxib on the proliferation and apoptosis of human prostate cancer cell line PC-3]Song Xu, Wen-quan Zhou, Zheng-yu Zhang, et al.
Zhonghua Nan Ke Xue = National Journal of Andrology|May 29, 2009
[Effects of endothelin A receptor antagonist BQ123 on the proliferation and apoptosis of prostate cancer cell line PC-3M]Song Xu, Wen-Quan Zhou, Zheng-Yu Zhang, et al.
Cancer Research|November 17, 2007
Silencing of prion protein sensitizes breast adriamycin-resistant carcinoma cells to TRAIL-mediated cell deathFranck Meslin, Ahmed Hamaï, Ping Gao, et al.
DNA and Cell Biology|December 14, 2011
Overexpression of SIRT6 in porcine fetal fibroblasts attenuates cytotoxicity and premature senescence caused by D-galactose and tert-butylhydroperoxideXiaoxian Xie, Hao Zhang, Ping Gao, et al.
Pharmaceutical Development and Technology|October 2, 2004
Application of a mixture experimental design in the optimization of a self-emulsifying formulation with a high drug loadPing Gao, Martha J Witt, Roy J Haskell, et al.
Bioorganic Chemistry|July 23, 2025
Targeting Urokinase-type plasminogen activator receptor (uPAR) in cancer therapy: Insights from the development of small-molecule inhibitorsHan Zhang, Zhinuo Xie, Song Xie, et al.
Frontiers in Pharmacology|November 12, 2025
Correction: Astragaloside IV alleviates tacrolimus-induced chronic nephrotoxicity via p62-Keap1-Nrf2 pathwayPing Gao, Xiaoyi Du, Lili Liu, et al.
Neurochemical Research|December 16, 2025
NEXN-AS1 Predicts the Occurrence of Post-Stroke Cognitive Impairment and Alleviates Inflammation and Oxidative Stress by Targeting the miR-92a-3p/NRF1 Axis : NEXN-AS1 Alleviates Inflammation and Oxidative Stress in PSCIKai Wang, Lu Yang, Chuanzhou Zhang, et al.
Diagnostic Pathology|June 27, 2013
RNAi targeting CXCR4 inhibits proliferation and invasion of esophageal carcinoma cellsTao Wang, Yanfang Mi, Linping Pian, et al.
American Journal of Cancer Research|July 27, 2017
UHRF1 promotes breast cancer progression by suppressing KLF17 expression by hypermethylating its promoterShui-Ping Gao, He-Fen Sun, Liang-Dong Li, et al.
Pageof 166